NCT05149144Completed
Comutti - A Research Project Dedicated to Finding Smart Ways of Using Technology for a Better Tomorrow for Everyone, Everywhere.
Source: ClinicalTrials.gov · Last updated 13 May 2025
Brief summary (registry, in English)
According to World Health Organization, worldwide one in 160 children has an ASD. About around 25% to 30% of children are unable to use verbal language to communicate (non-verbal ASD) or are minimally verbal, i.e., use fewer than 10 words (mv-ASD). The ability to communicate is a crucial life skill, and difficulties with communication can have a range of negative consequences such as poorer quality of life and behavioural difficulties. Communication interventions generally aim to improve children's ability to communicate either through speech or by supplementing speech with other means (e.g., sign language, pictures, or AAC - Advanced Augmented Communication tools). Individuals with non- verbal ASD or mv-ASD often communicate with people through vocalizations that in some cases have a self-consistent phonetic association to concepts (e.g., "ba" to mean "bathroom") or are onomatopoeic expressions (e.g., "woof" to refer to a dog). In most cases vocalizations sound arbitrary; even if they vary in tone, pitch, and duration depending it is extremely difficult to interpret the intended message or the individual's emotional or physical state they would convey, creating a barrier between the persons with ASD and the rest of the world that originate stress and frustration. Only caregivers who have long term acquaintance with the subjects are able to decode such wordless sounds and assign them to unique meanings. This project aims at defining algorithms, methods, and technologies to identify the communicative intent of vocal expressions generated by children with mv-ASD, and to create tools that help people who are not familiar with the subjects to understand these individuals during spontaneous conversations.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 33 (actual)
- First submitted
- 25 Nov 2021
- Start date
- 27 Jul 2021
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- IRCCS Eugenio Medea
- Diseases
- Autism
- NCT number
- NCT05149144
What you commit to
- Study type: Interventional
- Participants enrolled: 33
- From 27 Jul 2021 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- using any stimulant or non-stimulant medication affecting the central nervous system
Other illness
- having an identified genetic disorder
- suffering from chronic or acute medical illness
Other
- having vision or hearing problems
Who the study is looking for
- having a clinical diagnosis of autism spectrum disorder according to DSM-5 criteria
- use fewer than 10 words
Age in the registry: 2 years to 10 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Scientific Institute IRCCS Eugenio Medea Coordinator of this site? Confirm its status | Bosisio Parini | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.